Is Bristol Myers Squibb Stock a Buy?

Bristol Myers Squibb (NYSE: BMY) underperformed the S&P 500 index in each of the last four years, and it's on the way to extending the streak to five.

Does this lackluster track record mean that investors should look elsewhere? Or is Bristol Myers Squibb a stock to buy right now? To answer this question, we need to look at three key areas for the drugmaker.

Image source: Getty Images.

Continue reading


Source Fool.com